Factor This Power Engineering
Live Events
DTECH® Events
POWERGEN™
INFOCAST Events
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
POWERGEN™
INFOCAST Events
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
(OP:
NYMXF
)
0.0600
-0.0228 (-27.54%)
Streaming Delayed Price
Updated: 9:30 AM EDT, Jun 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about NYMXF
NYMOX Provides Current Update
June 02, 2026
Via
ACCESS Newswire
NYMOX Provides Recent Updates
March 27, 2026
Via
ACCESS Newswire
Nymox Announces Dismissal of Delaware Action Against Ascella
March 11, 2025
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
NYMOX Announces Trading Resumed and New Listing on OTCQB Market
December 17, 2024
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Announces Filing of Annual Report
August 30, 2024
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Annual Report
July 18, 2024
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Required to Resubmit Application to DKMA
July 16, 2024
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages
March 27, 2024
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox December 27 Message to Shareholders
December 27, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Reports California Court Issues Preliminary Injunction Against Defendants Lanham, Riley, Cutler and Others
November 30, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
$250 Million Lawsuit Filed Against AscellaHealth by Nymox Accepted and Summons Issued in California Court
November 21, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Pharmaceutical Corporation Sues AscellaHealth For $250 Million
November 09, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
NYMOX REPORTS: Bahamian Court Today Suspends Order of October 3, 2023 Rendering Riley-Lanham and Accomplices Planned Vote Unauthorized
November 03, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023
November 03, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
IMPORTANT MESSAGE TO NYMOX SHAREHOLDERS: NYMOX Cautions Against Unauthorized Improper Shareholder Meeting and Unauthorized Unregistered Solicitations
November 02, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
IMPORTANT NOTICE: NYMOX Cautions Shareholders Not to Take Calls or Participate in Unauthorized Improper Shareholder Meeting
October 31, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Notice: Nymox Informs Its Shareholders Not to Take Calls or Participate in An Unauthorized and Improper Shareholder Meeting
October 27, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Reports New NYMOZARFEX Marketing Application is Accepted For Review
October 26, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH
September 25, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Reports Completion of $2 Million Private Placement
August 29, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Announces $2 Million Private Placement
August 02, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox's 3-month ex-CFO was Awarded an Unauthorized and Undisclosed Treasury Directive for 100,000 Shares of Nymox Stock Without the Knowledge or Approval of the Nymox Board or Nymox’s CEO
July 31, 2023
Ex-CFO Provided to Nymox Before Appointment as CFO a Personal Resume with False Claim of Securing USD 62.5 million at his Previous Company
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
